FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2800664265> ?p ?o ?g. }

• W2800664265 abstract "Background— Although ticagrelor has improved clinical outcomes among patients with acute coronary syndrome compared with clopidogrel, adherence to this new antiplatelet agent in real-world practice has not been fully investigated. Methods and Results— Between November 2011 and June 2014, 1278 of 4831 consecutive patients (26.5%) undergoing percutaneous coronary intervention at a tertiary care center were treated with ticagrelor. Premature ticagrelor cessation was categorized into (1) change, when ticagrelor was replaced by prasugrel; (2) de-escalation, when ticagrelor was replaced by clopidogrel; and (3) premature discontinuation, when ticagrelor was discontinued without P2Y12 inhibitor replacement. Of 1278 patients treated with ticagrelor, premature treatment cessation occurred in 212 patients (17%). De-escalation to clopidogrel was the most frequent scenario (57%; n=120), followed by premature discontinuation (28%; n=60) and change to prasugrel (15%; n=32). Reasons for ticagrelor cessation included adverse effects (49%), initiation of oral anticoagulation (19%), and unspecified general practitioner preference (10%). Most frequent adverse effects leading to premature ticagrelor cessation were bleeding (41%), dyspnea (29%), and gastrointestinal symptoms (18%). Premature ticagrelor cessation was not associated with an increased risk of cardiac death, myocardial infarction, or stroke (hazard ratio, 0.73; 95% confidence interval: 0.40–1.32; P =0.29). Conclusions— Premature ticagrelor cessation in routine clinical practice occurred in 1 of 6 patients and was primarily related to adverse effects among which bleeding and dyspnea were the most frequent. Although premature ticagrelor cessation was not associated with adverse cardiovascular outcomes, this finding requires careful interpretation in view of the modest sample size. Clinical Trial Registration— URL: https://www.clinicaltrials.gov . Unique identifier: NCT02241291." @default.
• W2800664265 created "2018-05-17" @default.
• W2800664265 creator A5000190765 @default.
• W2800664265 creator A5016167046 @default.
• W2800664265 creator A5019587141 @default.
• W2800664265 creator A5040134218 @default.
• W2800664265 creator A5040786618 @default.
• W2800664265 creator A5042111387 @default.
• W2800664265 creator A5044884884 @default.
• W2800664265 creator A5047690226 @default.
• W2800664265 creator A5051530432 @default.
• W2800664265 creator A5052058613 @default.
• W2800664265 creator A5053194091 @default.
• W2800664265 creator A5060467171 @default.
• W2800664265 creator A5064844092 @default.
• W2800664265 creator A5066050469 @default.
• W2800664265 creator A5066913399 @default.
• W2800664265 creator A5067223258 @default.
• W2800664265 creator A5068440479 @default.
• W2800664265 creator A5076782898 @default.
• W2800664265 creator A5083609132 @default.
• W2800664265 date "2018-05-01" @default.
• W2800664265 modified "2023-10-13" @default.
• W2800664265 title "Frequency, Reasons, and Impact of Premature Ticagrelor Discontinuation in Patients Undergoing Coronary Revascularization in Routine Clinical Practice" @default.
• W2800664265 cites W158289124 @default.
• W2800664265 cites W175926515 @default.
• W2800664265 cites W2001167313 @default.
• W2800664265 cites W2049791623 @default.
• W2800664265 cites W2052713441 @default.
• W2800664265 cites W2083488580 @default.
• W2800664265 cites W2097648921 @default.
• W2800664265 cites W2113320440 @default.
• W2800664265 cites W2131181128 @default.
• W2800664265 cites W2133536883 @default.
• W2800664265 cites W2139189174 @default.
• W2800664265 cites W2140501627 @default.
• W2800664265 cites W2141358924 @default.
• W2800664265 cites W2160205454 @default.
• W2800664265 cites W2163050713 @default.
• W2800664265 cites W2170719271 @default.
• W2800664265 cites W2311337491 @default.
• W2800664265 cites W2361921955 @default.
• W2800664265 cites W2431546415 @default.
• W2800664265 cites W2434007950 @default.
• W2800664265 cites W2443764898 @default.
• W2800664265 cites W2536081172 @default.
• W2800664265 cites W2537558475 @default.
• W2800664265 cites W2543143993 @default.
• W2800664265 cites W2556414715 @default.
• W2800664265 cites W2578926377 @default.
• W2800664265 cites W2614154720 @default.
• W2800664265 cites W2736768805 @default.
• W2800664265 cites W2748517697 @default.
• W2800664265 cites W2752033985 @default.
• W2800664265 cites W2766257307 @default.
• W2800664265 cites W4236531408 @default.
• W2800664265 doi "https://doi.org/10.1161/circinterventions.117.006132" @default.
• W2800664265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29748219" @default.
• W2800664265 hasPublicationYear "2018" @default.
• W2800664265 type Work @default.
• W2800664265 sameAs 2800664265 @default.
• W2800664265 citedByCount "36" @default.
• W2800664265 countsByYear W28006642652019 @default.
• W2800664265 countsByYear W28006642652020 @default.
• W2800664265 countsByYear W28006642652021 @default.
• W2800664265 countsByYear W28006642652022 @default.
• W2800664265 countsByYear W28006642652023 @default.
• W2800664265 crossrefType "journal-article" @default.
• W2800664265 hasAuthorship W2800664265A5000190765 @default.
• W2800664265 hasAuthorship W2800664265A5016167046 @default.
• W2800664265 hasAuthorship W2800664265A5019587141 @default.
• W2800664265 hasAuthorship W2800664265A5040134218 @default.
• W2800664265 hasAuthorship W2800664265A5040786618 @default.
• W2800664265 hasAuthorship W2800664265A5042111387 @default.
• W2800664265 hasAuthorship W2800664265A5044884884 @default.
• W2800664265 hasAuthorship W2800664265A5047690226 @default.
• W2800664265 hasAuthorship W2800664265A5051530432 @default.
• W2800664265 hasAuthorship W2800664265A5052058613 @default.
• W2800664265 hasAuthorship W2800664265A5053194091 @default.
• W2800664265 hasAuthorship W2800664265A5060467171 @default.
• W2800664265 hasAuthorship W2800664265A5064844092 @default.
• W2800664265 hasAuthorship W2800664265A5066050469 @default.
• W2800664265 hasAuthorship W2800664265A5066913399 @default.
• W2800664265 hasAuthorship W2800664265A5067223258 @default.
• W2800664265 hasAuthorship W2800664265A5068440479 @default.
• W2800664265 hasAuthorship W2800664265A5076782898 @default.
• W2800664265 hasAuthorship W2800664265A5083609132 @default.
• W2800664265 hasBestOaLocation W28006642651 @default.
• W2800664265 hasConcept C126322002 @default.
• W2800664265 hasConcept C164705383 @default.
• W2800664265 hasConcept C197934379 @default.
• W2800664265 hasConcept C2777028646 @default.
• W2800664265 hasConcept C2777698277 @default.
• W2800664265 hasConcept C2777849778 @default.
• W2800664265 hasConcept C2778715236 @default.
• W2800664265 hasConcept C2780400711 @default.
• W2800664265 hasConcept C2780890252 @default.
• W2800664265 hasConcept C500558357 @default.
• W2800664265 hasConcept C71924100 @default.
• W2800664265 hasConceptScore W2800664265C126322002 @default.

• next